Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

NCT05512754 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-12-09

No results posted yet for this study

Summary

The purpose of this study is to assess the impact of ibuprofen in men with elevated serum PSA.

Conditions

  • Elevated Serum PSA

Interventions

DRUG

Ibuprofen 400 mg

400 mg tablet

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Scott Eggener, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05512754 on ClinicalTrials.gov